Abstract |
The characterization of a new human B cell-restricted activation antigen (B5) is described in this report. With the use of a monoclonal antibody to B5, we show that B5 can be detected on peripheral blood or splenic B cells after 1 day of stimulation with either anti- immunoglobulin, protein A, Epstein Barr virus, or pokeweed mitogen. In contrast, B5 was not expressed on resting B, T, or myeloid cells. More important, B5 could not be detected on activated T cells or monocytes. The B5 antigen was expressed on some lymphoblastoid B cell lines and B cell neoplasms but was not expressed on leukemias or lymphomas of T or myeloid origin. The B5 antigen is distinct from previously reported B cell activation antigens by its m.w. and pattern of cellular expression. These studies suggest that B5 is a novel B cell-restricted activation antigen, which may be useful to study the events of early human B cell activation.
|
Authors | A S Freedman, A W Boyd, K C Anderson, D C Fisher, S F Schlossman, L M Nadler |
Journal | Journal of immunology (Baltimore, Md. : 1950)
(J Immunol)
Vol. 134
Issue 4
Pg. 2228-35
(Apr 1985)
ISSN: 0022-1767 [Print] United States |
PMID | 2579134
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Antibodies, Monoclonal
- Antigens, Differentiation, B-Lymphocyte
- Antigens, Neoplasm
- Antigens, Surface
- Epitopes
|
Topics |
- Animals
- Antibodies, Monoclonal
(biosynthesis)
- Antigen-Antibody Reactions
- Antigens, Differentiation, B-Lymphocyte
- Antigens, Neoplasm
(analysis, immunology)
- Antigens, Surface
(immunology, isolation & purification)
- B-Lymphocytes
(immunology)
- Bone Marrow
(immunology)
- Cell Line
- Epitopes
(analysis)
- Female
- Humans
- Hybridomas
(metabolism)
- Lymphocyte Activation
- Lymphoid Tissue
(immunology)
- Mice
- Mice, Inbred BALB C
- Spleen
(cytology)
|